Purple Biotech (XTAE:PPBT) Price-to-Tangible-Book

: 2.11 (As of Today)

View and export this data going back to 1978. Start your Free Trial

As of today (2024-04-23), Purple Biotech's share price is ₪0.194. Purple Biotech's Tangible Book per Share of Dec. 2023 for the quarter that ended in Dec. 2023 was ₪0.09. Hence, Purple Biotech's Price to Tangible Book Ratio of today is 2.11.

The historical rank and industry rank for Purple Biotech's Price-to-Tangible-Book or its related term are showing as below:

XTAE:PPBT' s Price-to-Tangible-Book Range Over the Past 10 Years
Min: 0.96 Med: 2.08 Max: 18.94
Current: 2.16

During the past 11 years, Purple Biotech's highest Price to Tangible Book Ratio was 18.94. The lowest was 0.96. And the median was 2.08.

XTAE:PPBT's Price-to-Tangible-Book is ranked better than
58.15% of 1221 companies
in the Biotechnology industry
Industry Median: 2.67 vs XTAE:PPBT: 2.16

A closely related ratio is called PB Ratio. As of today, Purple Biotech's share price is ₪0.194. Purple Biotech's Book Value per Sharefor the quarter that ended in Dec. 2023 was ₪0.51. Hence, Purple Biotech's P/B Ratio of today is 0.38.

Purple Biotech Price-to-Tangible-Book Historical Data

The historical data trend for Purple Biotech's Price-to-Tangible-Book can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Purple Biotech Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Price-to-Tangible-Book

3.11

0.97

1.27

0.96

3.47

Purple Biotech Quarterly Data
	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Price-to-Tangible-Book																0.96	1.80	2.12	2.30	3.47

Competitive Comparison

For the Biotechnology subindustry, Purple Biotech's Price-to-Tangible-Book, along with its competitors' market caps and Price-to-Tangible-Book data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Purple Biotech Price-to-Tangible-Book Distribution

For the Biotechnology industry and Healthcare sector, Purple Biotech's Price-to-Tangible-Book distribution charts can be found below:

* The bar in red indicates where Purple Biotech's Price-to-Tangible-Book falls into.

Purple Biotech Price-to-Tangible-Book Calculation

Purple Biotech's price-to-tangible-book ratio for today is calculated as:

Price to Tangible Book	=	Share Price	/	Tangible Book per Share (Q: Dec. 2023 )
	=	0.194	/	0.092
	=	2.11

It can also be calculated from the numbers for the whole company:

Price to Tangible Book	=	Market Cap	/	Tangible Equity
	=	Market Cap	/	(Total Stockholders Equity	-	Preferred Stock	-	Intangible Assets)

A closely related ratio is called PB Ratio. The difference between Price-to-Tangible-Book Ratio and PB Ratio is that book value other than intangibles are used in the calculation.

Be Aware

Some businesses have very light assets, such as software companies or insurance agencies. The Price-to-Book Ratio does not work well for these companies. Some companies even have negative equity, so the Price-to-Book Ratio cannot be applied to them.

Purple Biotech Price-to-Tangible-Book Related Terms

Thank you for viewing the detailed overview of Purple Biotech's Price-to-Tangible-Book provided by GuruFocus.com. Please click on the following links to see related term pages.

Purple Biotech (XTAE:PPBT) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Purple Biotech Ltd (XTAE:PPBT) » Definitions » Price-to-Tangible-Book

Comparable Companies

Traded in Other Exchanges

PPBT:USA 1YI1:Germany

Address

4 Oppenheimer Street, Science Park, Rehovot, ISR, 7670104

Website

https://www.purple-biotech.com

Purple Biotech Ltd is a clinical-stage company focused on advancing first-in-class therapies to overcome tumor immune evasion and drug resistance, and to create treatments for people with cancer. Its oncology pipeline includes NT219 and CM24.